HQL
Tekla Life Sciences Investors
18.20$
+4.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q3 23 | Q1 25 | Q3 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 0.0% | – | – | -0.1% | 0.0% | 0.0% | 0.0% | – | -5.7% | -11.0% | -2.5% | |
| – | – | – | – | – | – | – | – | – | -0.4% | -1.1% | 0.3% | |
| – | 0.0% | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | – | – | – | – | – | – | – | – | 24.1% | 179.0% | 21.2% | |
| – | – | – | – | – | – | – | – | – | – | 271.9% | 37.8% | |
| – | – | – | – | – | – | – | – | – | -46.2% | -199.6% | -34.5% | |
| – | 0.0% | – | 0.0% | -0.1% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.6% | -0.2% | |
| – | 0.0% | – | – | -0.1% | 0.0% | 0.0% | 0.0% | – | -5.7% | -11.0% | -2.5% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.